Global public health efforts to address HIV and related communicable disease
暂无分享,去创建一个
[1] P. Easterbrook,et al. Prevalence and burden of HBV co‐infection among people living with HIV: A global systematic review and meta‐analysis , 2019, Journal of viral hepatitis.
[2] Maria H. Kim,et al. Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list. , 2019, The lancet. HIV.
[3] M. Unemo,et al. Diagnosing sexually transmitted infections in resource‐constrained settings: challenges and ways forward , 2019, Journal of the International AIDS Society.
[4] S. Lockman,et al. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana. , 2019, The New England journal of medicine.
[5] N. Ford,et al. Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects , 2019, Journal of the International AIDS Society.
[6] Monika Roy,et al. A Review of Differentiated Service Delivery for HIV Treatment: Effectiveness, Mechanisms, Targeting, and Scale , 2019, Current HIV/AIDS Reports.
[7] K. Dheda,et al. What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment? , 2019, The Indian journal of medical research.
[8] D. Falzon,et al. Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis , 2018, Bulletin of the World Health Organization.
[9] N. Ford,et al. Sensitivity and specificity of WHO's recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis. , 2018, The lancet. HIV.
[10] N. Ford,et al. The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues? , 2018, AIDS.
[11] R. Shapiro,et al. Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception. , 2018, The New England journal of medicine.
[12] T. Klimkait,et al. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial , 2018, JAMA.
[13] T. Le. World Health Organization Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy , 2018 .
[14] R. Peeling,et al. Point-of-care tests for STIs: the way forward , 2017, Sexually Transmitted Infections.
[15] N. Ford,et al. The WHO public health approach to HIV treatment and care: looking back and looking ahead. , 2017, The Lancet. Infectious diseases.
[16] N. Ford,et al. When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank , 2017, Current opinion in HIV and AIDS.
[17] N. Ford,et al. The evolving role of CD4 cell counts in HIV care , 2017, Current opinion in HIV and AIDS.
[18] P. Easterbrook,et al. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.
[19] K. Looker,et al. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] N. Ford,et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression , 2016, Journal of the International AIDS Society.
[21] G. Rutherford,et al. Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization , 2014, AIDS.
[22] N. Ford,et al. Decentralising HIV treatment in lower- and middle-income countries , 2013, The Cochrane database of systematic reviews.
[23] K. Venkatesh,et al. Interactions of HIV, Other Sexually Transmitted Diseases, and Genital Tract Inflammation Facilitating Local Pathogen Transmission and Acquisition , 2011, American journal of reproductive immunology.
[24] M. Singer,et al. Generations of Suffering: Experiences of a Treatment Program for Substance Abuse During Pregnancy , 2010, Journal of health care for the poor and underserved.
[25] S. Gove,et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings , 2006, The Lancet.
[26] D. Fleming,et al. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. , 1999, Sexually transmitted infections.
[27] A. Korobitsyn. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV , 2019 .
[28] G. Indolfi. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection , 2018 .
[29] Á. Száz. Minimal structures , generalized topologies , and ascending systems should not be studied without generalized uniformities , 2007 .